LISATA THERAPEUTICS, INC. Quarterly Depreciation in USD from Q1 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Lisata Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2022 to Q1 2024.
  • Lisata Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $29K, a 3.33% decline year-over-year.
  • Lisata Therapeutics, Inc. annual Depreciation for 2023 was $100K, unchanged from 2022.
  • Lisata Therapeutics, Inc. annual Depreciation for 2022 was $100K, unchanged from 2021.
  • Lisata Therapeutics, Inc. annual Depreciation for 2021 was $100K, unchanged from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $29K -$1K -3.33% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q2 2023 $60K +$47K +362% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $30K +$23K +329% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q2 2022 $13K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $7K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.